Sean Pavone / Shutterstock.com

7 January 2025NewsCareersMarisa Woutersen

Troutman Pepper Locke exodus sees teams leave in Chicago and London

Two large teams leave Locke Lord following Troutman Pepper merger | Buchanan opens Chicago office with a large life sciences group | Shoosmiths adds team in London to expand brand-focused IP services.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Paul, Weiss swoops for senior duo from Weil, Gotshal

21 November 2024 The firm brings two life sciences and tech experts to its litigation department | Pair bring combined experience of 45 years from Weil, Gotshal & Manges | Duo offer expertise handling cases for pharmaceutical, biotechnology, and technology clients.

WBD to merge with firm to create ‘powerhouse’ practice

12 September 2024 Deal marks the third major M&A to be announced so far this month | Combined firms have a total gross revenue of more than $742 million | Business marriage seen as “natural fit and clear win-win”.

More on this story

Paul, Weiss swoops for senior duo from Weil, Gotshal

21 November 2024 The firm brings two life sciences and tech experts to its litigation department | Pair bring combined experience of 45 years from Weil, Gotshal & Manges | Duo offer expertise handling cases for pharmaceutical, biotechnology, and technology clients.

WBD to merge with firm to create ‘powerhouse’ practice

12 September 2024 Deal marks the third major M&A to be announced so far this month | Combined firms have a total gross revenue of more than $742 million | Business marriage seen as “natural fit and clear win-win”.

More on this story

Paul, Weiss swoops for senior duo from Weil, Gotshal

21 November 2024 The firm brings two life sciences and tech experts to its litigation department | Pair bring combined experience of 45 years from Weil, Gotshal & Manges | Duo offer expertise handling cases for pharmaceutical, biotechnology, and technology clients.

WBD to merge with firm to create ‘powerhouse’ practice

12 September 2024 Deal marks the third major M&A to be announced so far this month | Combined firms have a total gross revenue of more than $742 million | Business marriage seen as “natural fit and clear win-win”.

More features

$740M deal ends COVID-19 vaccine feud between CureVac and BioNTech

CyDex trade secrets case tossed by Italian court in rare ruling

Chemical reaction: Why AI drug discovery demands a new IP plan

EIP strengthens UPC offering with new hire

European Patent Office’s G1/25 referral under the microscope

Pfizer loses UK appeal over Moderna Covid-19 vaccine patent

WATCH: UPC update—shaping patent litigation

Bayer’s Xarelto patent struck down by German court